Empirical Finance’s Globus Medical GMED Stock Holding History

Empirical Finance’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,258	Closed	-$265K	–	161
2018 Q2	$265K	Buy	+5,258	New	+$274K	0.07%	116

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Empirical Finance's GMED Position: Q3 2018 in Review

Empirical Finance sold out of Globus Medical (GMED) in Q3 2018, closing a stake of 5,258 shares — an estimated $265K sold.

Empirical Finance first reported a position in GMED in Q2 2018 and held it in 1 quarter. The position peaked at $265K in Q2 2018. 312 funds tracked by Wall St. Rank hold GMED as of Q3 2018.

Empirical Finance reported no remaining Globus Medical position as of Q3 2018 after selling out during the quarter.
Empirical Finance sold 5,258 Globus Medical shares in Q3 2018, an estimated $265K.
Empirical Finance first reported a position in Globus Medical in Q2 2018 and held it in 1 quarter.
Empirical Finance's Globus Medical position peaked at $265K in Q2 2018.
312 funds tracked by Wall St. Rank held Globus Medical as of Q3 2018.

Based on Empirical Finance's 13F filing for Q3 2018, filed 18 Oct 2018.